Abstract
Purpose
Frailty, polypharmacy, and underprescription are considered a major matter of concern in nursing homes, but the possible relationships between them are not well known. The aim is to examine the possible association between medication underprescription, polypharmacy, and frailty in older people living in nursing homes.
Methods
A cross-sectional analysis from a concurrent cohort study, including 110 subjects ≥ 65 years living in two nursing homes. Four frailty scales were applied; polypharmacy was defined as ≥ 5 medications and underprescription was measured with Screening Tool to Alert to Right Treatment (START) criteria. Logistic regression models were performed to assess the associations.
Results
The mean age was 86.3 years (SD 7.3) and 71.8% were female. 73.6% of subjects took ≥ 5 chronic medications and 60.9% met one or more START criteria. The non-frail participants took more medications than the frail subjects according to the imputated frailty Fried criteria (8.1 vs 6.7, p = 0.042) and the FRAIL-NH scale (7.8 vs 6.8, p = 0.026). Multivariate analyses did not find an association between frailty and polypharmacy. Frail participants according to the Fried criteria met a higher number of START criteria (1.9 vs 1.0, p = 0.017), and had a higher prevalence of underprescription (87.5 vs 50.0%), reaching the limit of statistical significance in multivariate analysis.
Conclusion
The positive association found in previous studies between frailty and polypharmacy cannot be extrapolated to institutionalized populations. There is a trend towards higher rates of underprescription in frail subjects. Underprescription in frail older adults should be redefined and new strategies to measure it should be developed.
Similar content being viewed by others
References
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K (2013) Frailty in elderly people. Lancet 381(9868):752–762. https://doi.org/10.1016/S0140-6736(12)62167-9
Rodríguez-Mañas L, Féart C, Mann G, Viña J, Chatterji S, Chodzko-Zajko W, Gonzalez-Colaço Harmand M, Bergman H, Carcaillon L, Nicholson C, Scuteri A, Sinclair A, Pelaez M, Van der Cammen T, Beland F, Bickenbach J, Delamarche P, Ferrucci L, Fried LP, Gutiérrez-Robledo LM, Rockwood K, Rodríguez Artalejo F, Serviddio G, Vega E, 1) F-CgA (2013) Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci 68(1):62–67. https://doi.org/10.1093/gerona/gls119
Luo H, Lum TYS, Wong GHY, Kwan JSK, Tang JYM, Chi I (2015) Predicting adverse health outcomes in nursing homes: a 9-year longitudinal study and development of the FRAIL-Minimum Data Set (MDS) Quick Screening Tool. J Am Med Dir Assoc 16(12):1042–1047. https://doi.org/10.1016/j.jamda.2015.09.006
Kojima G (2016) Frailty as a predictor of nursing home placement among community-dwelling older adults: a systematic review and meta-analysis. J Geriatr Phys Ther 41:42–48. https://doi.org/10.1519/JPT.0000000000000097
Buckinx F, Reginster JY, Petermans J, Croisier JL, Beaudart C, Brunois T, Bruyère O (2016) Relationship between frailty, physical performance and quality of life among nursing home residents: the SENIOR cohort. Aging Clin Exp Res 28(6):1149–1157. https://doi.org/10.1007/s40520-016-0616-4
de la Rica-Escuín M, González-Vaca J, Varela-Pérez R, Arjonilla-García MD, Silva-Iglesias M, Oliver-Carbonell JL, Abizanda P (2014) Frailty and mortality or incident disability in institutionalized older adults: the FINAL study. Maturitas 78(4):329–334. https://doi.org/10.1016/j.maturitas.2014.05.022
Veronese N, Stubbs B, Noale M, Solmi M, Pilotto A, Vaona A, Demurtas J, Mueller C, Huntley J, Crepaldi G, Maggi S (2017) Polypharmacy is associated with higher frailty risk in older people: an 8-year longitudinal cohort study. J Am Med Dir Assoc 18(7):624–628. https://doi.org/10.1016/j.jamda.2017.02.009
Saum KU, Schottker B, Meid AD, Holleczek B, Haefeli WE, Hauer K, Brenner H (2017) Is polypharmacy associated with frailty in older people? Results from the ESTHER Cohort Study. J Am Geriatr Soc 65(2):e27–e32. https://doi.org/10.1111/jgs.14718
Merchant RA, Chen MZ, Tan LWL, Lim MY, Ho HK, van Dam RM (2017) Singapore Healthy Older People Everyday (HOPE) Study: prevalence of frailty and associated factors in older adults. J Am Med Dir Assoc 18(8):734.e739–734.e714. https://doi.org/10.1016/j.jamda.2017.04.020
Maher RL, Hanlon J, Hajjar ER (2014) Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 13(1):57–65. https://doi.org/10.1517/14740338.2013.827660
Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D (2008) STOPP (Screening Tool of Older person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 46(2):72–83
O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P (2015) STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44(2):213–218. https://doi.org/10.1093/ageing/afu145
Kojima G (2015) Prevalence of frailty in nursing homes: a systematic review and meta-analysis. J Am Med Dir Assoc 16(11):940–945. https://doi.org/10.1016/j.jamda.2015.06.025
Cherubini A, Corsonello A, Lattanzio F (2016) Polypharmacy in nursing home residents: what is the way forward? J Am Med Dir Assoc 17(1):4–6. https://doi.org/10.1016/j.jamda.2015.07.008
García-Gollarte F, Baleriola-Júlvez J, Ferrero-López I, Cruz-Jentoft AJ (2012) Inappropriate drug prescription at nursing home admission. J Am Med Dir Assoc 13(1):83.e89–83.e15. https://doi.org/10.1016/j.jamda.2011.02.009
Kuijpers MA, van Marum RJ, Egberts AC, Jansen PA, Group OS (2008) Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 65(1):130–133. https://doi.org/10.1111/j.0306-5251.2007.02961.x
Meid AD, Quinzler R, Freigofas J, Saum KU, Schottker B, Holleczek B, Heider D, Konig HH, Brenner H, Haefeli WE (2015) Medication underuse in aging outpatients with cardiovascular disease: prevalence, determinants, and outcomes in a prospective cohort study. PLoS One 10(8):e0136339. https://doi.org/10.1371/journal.pone.0136339
Lefebvre MC, St-Onge M, Glazer-Cavanagh M, Bell L, Kha Nguyen JN, Viet-Quoc Nguyen P, Tannenbaum C (2016) The effect of bleeding risk and frailty status on anticoagulation patterns in octogenarians with atrial fibrillation: the FRAIL-AF study. Can J Cardiol 32(2):169–176. https://doi.org/10.1016/j.cjca.2015.05.012
Perera V, Bajorek BV, Matthews S, Hilmer SN (2009) The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation. Age Ageing 38(2):156–162. https://doi.org/10.1093/ageing/afn293
Martínez-Velilla N, Herce PA, Herrero ÁC, Gutiérrez-Valencia M, Sáez de Asteasu ML, Mateos AS, Zubillaga AC, Beroiz BI, Jiménez AG, Izquierdo M (2017) Heterogeneity of different tools for detecting the prevalence of frailty in nursing homes: feasibility and meaning of different approaches. J Am Med Dir Assoc 18(10):898.e891–898.e898. https://doi.org/10.1016/j.jamda.2017.06.016
Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel index. Md State Med J 14:61–65
Salva A, Coll-Planas L, Bruce S, De Groot L, Andrieu S, Abellan G, Vellas B, Bartorelli L, Berner YN, Corman B, Domingo A, Egger TP, de Groot L, Guigoz Y, Imedio A, Planas M, Porras C, Rovira JC, Salvà A, Serra JA, Task Force on Nutrition and Ageing of the IAGG and the IANA (2009) Nutritional assessment of residents in long-term care facilities (LTCFs): recommendations of the task force on nutrition and ageing of the IAGG European region and the IANA. J Nutr Health Aging 13(6):475–483
Lobo A, Ezquerra J, Gómez-Burgada F, Sala J, Seva-Díaz A (1979) El Mini-Examen Cognoscitivo: Un test sencillo y práctico para detectar alteraciones intelectuales en pacientes médicos. Actas Luso-Esp Neurol Psiquiatr 7:189e202 189–202
Martínez de la Iglesia J, Onís Vilches M, Dueñas Herrero R, Aguado Taberné C, Albert Colomer C, Luque Luque R (2002) Versión española del cuestionario de Yesavage abreviado (GDS) para el cribado de depresión en mayores de 65 años: Adaptación y validación. Medifam 12(10):26-40 http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1131-57682002001000003&lng=es.
Martínez-Velilla N, Cambra-Contin K, Ibáñez-Beroiz B (2014) Comorbidity and prognostic indices do not improve the 5-year mortality prediction of components of comprehensive geriatric assessment in hospitalized older patients. BMC Geriatr 14:64. https://doi.org/10.1186/1471-2318-14-64
WHO (2018) Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index. https://www.whocc.no/atc_ddd_index/ Accessed 18 February 2018
Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE (2017) What is polypharmacy? A systematic review of definitions. BMC Geriatr 17(1):230. https://doi.org/10.1186/s12877-017-0621-2
Jokanovic N, Tan EC, Dooley MJ, Kirkpatrick CM, Bell JS (2015) Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review. J Am Med Dir Assoc 16(6):535.e531–535.e512. https://doi.org/10.1016/j.jamda.2015.03.003
Bonaga B, Sánchez-Jurado PM, Martínez-Reig M, Ariza G, Rodríguez-Mañas L, Gnjidic D, Salvador T, Abizanda P (2017) Frailty, polypharmacy, and health outcomes in older adults: the frailty and dependence in Albacete study. J Am Med Dir Assoc 19:46–52. https://doi.org/10.1016/j.jamda.2017.07.008
Thai M, Hilmer S, Pearson SA, Reeve E, Gnjidic D (2015) Prevalence of potential and clinically relevant statin-drug interactions in frail and robust older inpatients. Drugs Aging 32(10):849–856. https://doi.org/10.1007/s40266-015-0302-9
Ballew SH, Chen Y, Daya NR, Godino JG, Windham BG, McAdams-DeMarco M, Coresh J, Selvin E, Grams ME (2017) Frailty, kidney function, and polypharmacy: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis 69(2):228–236. https://doi.org/10.1053/j.ajkd.2016.08.034
Bennett A, Gnjidic D, Gillett M, Carroll P, Matthews S, Johnell K, Fastbom J, Hilmer S (2014) Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study. Drugs Aging 31(3):225–232. https://doi.org/10.1007/s40266-013-0151-3
Herr M, Robine JM, Pinot J, Arvieu JJ, Ankri J (2015) Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people. Pharmacoepidemiol Drug Saf 24(6):637–646. https://doi.org/10.1002/pds.3772
Hasan SS, Kow CS, Verma RK, Ahmed SI, Mittal P, Chong DWK (2017) An evaluation of medication appropriateness and frailty among residents of aged care homes in Malaysia: a cross-sectional study. Medicine 96(35):e7929. https://doi.org/10.1097/md.0000000000007929
Kelly A, Conell-Price J, Covinsky K, Cenzer IS, Chang A, Boscardin WJ, Smith AK (2010) Length of stay for older adults residing in nursing homes at the end of life. J Am Geriatr Soc 58(9):1701–1706. https://doi.org/10.1111/j.1532-5415.2010.03005.x
Cullinan S, O’Mahony D, O’Sullivan D, Byrne S (2016) Use of a frailty index to identify potentially inappropriate prescribing and adverse drug reaction risks in older patients. Age Ageing 45(1):115–120. https://doi.org/10.1093/ageing/afv166
Poudel A, Peel NM, Nissen LM, Mitchell CA, Gray LC, Hubbard RE (2016) Adverse outcomes in relation to polypharmacy in robust and frail older hospital patients. J Am Med Dir Assoc 17(8):767.e769–767.e713. https://doi.org/10.1016/j.jamda.2016.05.017
Lang PO, Hasso Y, Dramé M, Vogt-Ferrier N, Prudent M, Gold G, Michel JP (2010) Potentially inappropriate prescribing including under-use amongst older patients with cognitive or psychiatric co-morbidities. Age Ageing 39(3):373–381. https://doi.org/10.1093/ageing/afq031
Parsons C, Lapane K, Kerse N, Hughes C (2011) Prescribing for older people in nursing homes: a review of the key issues. Int J Older People Nursing 6(1):45–54. https://doi.org/10.1111/j.1748-3743.2010.00264.x
Sloane PD, Gruber-Baldini AL, Zimmerman S, Roth M, Watson L, Boustani M, Magaziner J, Hebel JR (2004) Medication undertreatment in assisted living settings. Arch Intern Med 164(18):2031–2037. https://doi.org/10.1001/archinte.164.18.2031
Romero-Ortuno R, O’Shea D (2013) Fitness and frailty: opposite ends of a challenging continuum! Will the end of age discrimination make frailty assessments an imperative? Age Ageing 42(3):279–280. https://doi.org/10.1093/ageing/afs189
van den Heuvel PM, Los M, van Marum RJ, Jansen PA (2011) Polypharmacy and underprescribing in older adults: rational underprescribing by general practitioners. J Am Geriatr Soc 59(9):1750–1752. https://doi.org/10.1111/j.1532-5415.2011.03548.x
Lozano-Montoya I, Velez-Diaz-Pallares M, Delgado-Silveira E, Montero-Errasquin B, Cruz Jentoft AJ (2015) Potentially inappropriate prescribing detected by STOPP-START criteria: are they really inappropriate? Age Ageing 44:861–866. https://doi.org/10.1093/ageing/afv079
Lang P, Petrovic M, Dalleur O, Ferahta N, Benetos A, Boland B (2016) The exercise in applying STOPP/START.v2 in vulnerable very old patients: towards patient tailored prescribing. Eur Geriatric Med 7(2):176–179. https://doi.org/10.1016/j.eurger.2015.12.013
Gill TM, Gahbauer EA, Allore HG, Han L (2006) Transitions between frailty states among community-living older persons. Arch Intern Med 166(4):418–423. https://doi.org/10.1001/archinte.166.4.418
Hubbard RE, O’Mahony MS, Woodhouse KW (2013) Medication prescribing in frail older people. Eur J Clin Pharmacol 69(3):319–326. https://doi.org/10.1007/s00228-012-1387-2
Sinclair A, Abdelhafiz A, Dunning T, Izquierdo M, Rodriguez Manas L, Bourdel-Marchasson I, Morley J, Munshi M, Woo J, Vellas B (2017) An International Position Statement on the Management of Frailty in Diabetes Mellitus: Summary of Recommendations. J Frailty Aging. https://doi.org/10.14283/jfa.2017.39
Lavan AH, Gallagher P, Parsons C, O’Mahony D (2017) STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing 46(4):600–607. https://doi.org/10.1093/ageing/afx005
Caballero-Mora MA, Rodriguez-Mañas L (2017) STOPPFrail: a misleading name for a potentially useful tool. Age Ageing 46(5):874–875. https://doi.org/10.1093/ageing/afx139
Funding
This project has been funded by the TransPyrenean Biomedical Research Network (REFBIO) for the establishment of a network of stable collaboration among biomedical research centers in the Pyrenees Area (European Program INTERREG IV POCTEFA-A; REFBIO13/BIOD/002). The funder had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
Gutiérrez-Valencia M and Martínez-Velilla N have contributed to conception and design, acquisition, analysis and interpretation of data, drafting the article, and final approval of the version to be published. Izquierdo M, Lacalle-Fabo E, Marín-Epelde I, Ramón-Espinoza MF, Domene-Domene T, Casas Herrero Á, and Galbete A have contributed to conception and design, analysis and interpretation of data, revising the text, and final approval of the version to be published.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Electronic supplementary material
ESM 1
(DOC 23 kb)
Rights and permissions
About this article
Cite this article
Gutiérrez-Valencia, M., Izquierdo, M., Lacalle-Fabo, E. et al. Relationship between frailty, polypharmacy, and underprescription in older adults living in nursing homes. Eur J Clin Pharmacol 74, 961–970 (2018). https://doi.org/10.1007/s00228-018-2452-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-018-2452-2